Form 4: RenovoRx Chief Medical Officer Increases Stake in Company
SEC Form 4 Filing
Ramtin Agah, Chief Medical Officer of RenovoRx, Inc., purchased 20,000 shares of common stock at $0.80 per share.
Summary
- Ramtin Agah, the Chief Medical Officer of RenovoRx, Inc., has reported a transaction involving the company's stock.
- On April 11, 2025, Agah purchased 20,000 shares of common stock at a price of $0.80 per share.
- Following this transaction, Agah directly owns 1,098,460 shares of RenovoRx, Inc.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive due to insider buying, which often signals confidence in the company's prospects. However, it's a single transaction and doesn't provide a comprehensive view.
Positives
- The Chief Medical Officer's purchase of shares may signal confidence in the company's future prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that a company insider believes the company's stock is undervalued or that the company is expected to perform well in the future.
Key Dates
| Date | Description |
|---|---|
| 04/11/2025 | Date of the stock purchase transaction |
| 04/14/2025 | Date of signature on the Form 4 filing |
Keywords
RenovoRx, RNXT, Ramtin Agah, Chief Medical Officer, Stock Purchase, Beneficial Ownership, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.